TABLE 3.
Linear regression analysis predicting each NIH motor assessment outcome by ROI biomarker burden for those cognitively healthy | ||||||
---|---|---|---|---|---|---|
Grip | Walking speed | Dexterity | ||||
Neurodegeneration | β | p | β | p | β | p |
Precentral cortex | 0.046 | 0.519 | 0.181 | 0.036 | 0.172 | 0.072 |
Parahippocampus | 0.135 | 0.135 | 0.053 | 0.544 | 4.147 | 0.015 |
Entorhinal | 0.053 | 0.462 | 0.111 | 0.212 | 0.283 | 0.003 |
Aβ burden | ||||||
Precentral cortex | −0.082 | 0.508 | −0.205 | 0.294 | −0.025 | 0.897 |
Parahippocampus | −0.165 | 0.173 | −0.195 | 0.278 | −0.158 | 0.408 |
Hippocampus | −0.059 | 0.622 | 0.091 | 0.686 | 0.021 | 0.911 |
Tau burden | ||||||
Precentral cortex | −0.120 | 0.321 | −0.386 | 0.046 | −0.065 | 0.754 |
Parahippocampus | −0.251 | 0.036 | −0.195 | 0.276 | −0.220 | 0.292 |
Hippocampus | −0.141 | 0.296 | −0.173 | 0.440 | −0.401 | 0.072 |
Note: All models were controlled for participant age and sex and corrected for multiple comparisons using the Benjamini–Hochberg (1995) procedure. The NIH motor assessment outcomes included the grip strength dynamometer, 2‐minute walking speed, and 9‐hole peg dexterity tests.
Abbreviations: Aβ, amyloid beta; NIH, National Institutes of Health; ROI, region of interest.